ARCHIVES

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

Three researchers share Paul Marks Prize.

November 11, 2005

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

Excitement building toward 2015 goal, NCI director says in FY07 bypass budget request. NCI seeks $5.8 billion.

December 2, 2005

ACS Encourages Research Proposals Psychosocial Aspects Of Cancer

March 26, 1982

Clinical Oncology Grant Funding: The History Of a Controversy

July 23, 1993

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005